STOCK TITAN
  1. Home
  2. Sec-filings
  3. BHC
  4. [Form 4] Bausch Health Companies Inc Insider Trading Activity

[Form 4] Bausch Health Companies Inc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock BHC logo
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

#2521 Ranked by Market Cap
N/A Ranked by Dividends

BHC Latest News

Jul 10, 2025
CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs
Jul 10, 2025
Bausch Health Appoints New Chief Accounting Officer
Jul 9, 2025
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs
Jul 7, 2025
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
Jul 2, 2025
Bausch Health to Announce Second Quarter 2025 Results on July 30

BHC Latest SEC Filings

Jul 18, 2025
[Form 4] Bausch Health Companies Inc Insider Trading Activity
Jul 15, 2025
[Form 4] Bausch Health Companies Inc Insider Trading Activity
Jul 15, 2025
[Form 3] Bausch Health Companies Inc Initial Statement of Beneficial Ownership
Jul 10, 2025
[8-K] Bausch Health Companies Inc Reports Material Event
Jul 2, 2025
[Form 4] Bausch Health Companies Inc Insider Trading Activity

BHC Stock Data

2.45B
323.52M
11.31%
70.94%
1.75%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Canada
QUEBEC